McAndrew Rudisill - 08 Aug 2025 Form 4 Insider Report for 180 Life Sciences Corp. (ATNF)

Reporting relationship: Director, Executive Chairman
Issuer ticker: ATNF
Reported as of: 08 Aug 2025
Net transaction value: $0
SEC form: 4
Accepted by SEC: 12 Aug 2025, 17:20:03 UTC
Prior SEC filing: 07 Aug 2025
Next SEC filing: 03 Dec 2025
Source filing: View source filing
Reporting owner signature: /s/ McAndrew Rudisill

Key filing fact

McAndrew Rudisill filed Form 4 for 180 Life Sciences Corp. (ATNF) on 12 Aug 2025.

Key facts

This page summarizes McAndrew Rudisill's Form 4 filing for 180 Life Sciences Corp. (ATNF).
1 reported transaction and 2 derivative rows are listed below.
Accepted by SEC: 12 Aug 2025, 17:20.

Change

Previous filing in this sequence was filed on 07 Aug 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001511937 Primary reporting owner

Rudisill McAndrew

Relationship: Director, Executive Chairman
Address: 3000 EL CAMINO REAL, BLDG. 4,, SUITE 200, PALO ALTO
Signature: /s/ McAndrew Rudisill
Signature date: 12 Aug 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ATNF holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 37,735
Date: 08 Aug 2025
Ownership: By BER I LLC
Footnotes: F1

ATNF holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 37,735
Date: 08 Aug 2025
Ownership: By GER I LLC
Footnotes: F2

ATNF holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 37,735
Date: 08 Aug 2025
Ownership: By MRR I LLC
Footnotes: F3

ATNF holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 452,830
Date: 08 Aug 2025
Ownership: By Pelagic Capital Advisors LLC
Footnotes: F4

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

ATNF transaction Derivative

Warrant to Purchase Common Stock

Award

Transaction value: $0
Shares: +957,002
Change %
Price: $0.000000
Shares after: 957,002
Date: 08 Aug 2025
Ownership: By PCAO LLC
Underlying class: Common Stock
Underlying amount: 957,002
Exercise price: $3.44
Footnotes: F5, F6, F7, F8

ATNF holding Derivative

Warrant to Purchase Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 4,807,873
Date: 08 Aug 2025
Ownership: By PCAO LLC
Underlying class: Common Stock
Underlying amount: 4,807,873
Exercise price: $2.78
Footnotes: F5, F6, F8

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 8 footnotes

Footnote F1

The Reporting Person is the managing partner of BER I LLC ("BER"), and therefore may be deemed to beneficially own the securities held by BER. Mr. Rudisill disclaims beneficial ownership of the shares of common stock owned directly by BER, except to the extent of his pecuniary interest therein and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose.

Footnote F2

The Reporting Person is the managing partner of GER I LLC ("GER"), and therefore may be deemed to beneficially own the securities held by GER. Mr. Rudisill disclaims beneficial ownership of the shares of common stock owned directly by GER, except to the extent of his pecuniary interest therein and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose.

Footnote F3

The Reporting Person is the managing partner of MRR I LLC ("MRR"), and therefore may be deemed to beneficially own the securities held by MRR. Mr. Rudisill disclaims beneficial ownership of the shares of common stock owned directly by MRR, except to the extent of his pecuniary interest therein and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose.

Footnote F4

The Reporting Person is the managing partner and founder of Pelagic Capital Advisors LLC ("Pelagic"), and therefore may be deemed to beneficially own the securities held by Pelagic. Mr. Rudisill disclaims beneficial ownership of the shares of common stock owned directly by Pelagic, except to the extent of his pecuniary interest therein and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose.

Footnote F5

These warrants are currently exercisable, subject to a blocker provision that prevents PCAO (defined below) from exercising the warrants if it would be more than a 4.99% beneficial owner of the outstanding shares of the Issuer's common stock following such exercise, which percentage may be increased to up to 19.99% with at least 61 days prior written notice to the Issuer.

Footnote F6

The warrants have no expiration date.

Footnote F7

Issued in consideration for advisory and consulting services agreed to be rendered by PCAO.

Footnote F8

The Reporting Person is the managing partner of PCAO LLC ("PCAO"), and therefore may be deemed to beneficially own the securities held by such entity. Mr. Rudisill disclaims beneficial ownership of the shares of securities owned directly by PCAO, except to the extent of his pecuniary interest therein and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose.